An analysis of 70 tumours from patients with sporadic ovarian cancer for BRCA1 mRNA expression correlated low BRCA1 mRNA expression with improved survival following platinum-based chemotherapy [109]. The gene discussed is BRCA1; the disease is ovarian cancer.